PALAZZUOLI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 3.917
EU - Europa 2.998
AS - Asia 763
SA - Sud America 39
AF - Africa 9
OC - Oceania 5
Totale 7.731
Nazione #
US - Stati Uniti d'America 3.912
GB - Regno Unito 884
IE - Irlanda 577
CN - Cina 453
SE - Svezia 331
UA - Ucraina 284
RU - Federazione Russa 229
IT - Italia 226
DE - Germania 152
SG - Singapore 150
FR - Francia 122
VN - Vietnam 121
FI - Finlandia 98
BR - Brasile 34
BE - Belgio 27
CZ - Repubblica Ceca 19
ES - Italia 10
NL - Olanda 9
TR - Turchia 8
GR - Grecia 7
IN - India 7
CI - Costa d'Avorio 5
AU - Australia 4
CA - Canada 4
HK - Hong Kong 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
PE - Perù 3
AT - Austria 2
BD - Bangladesh 2
BG - Bulgaria 2
DK - Danimarca 2
EG - Egitto 2
IM - Isola di Man 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
RS - Serbia 2
UZ - Uzbekistan 2
AL - Albania 1
AR - Argentina 1
CH - Svizzera 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
JO - Giordania 1
JP - Giappone 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 7.731
Città #
Southend 792
Dublin 570
Fairfield 563
Ashburn 350
Chandler 326
Woodbridge 289
Ann Arbor 277
Houston 262
Jacksonville 229
Santa Clara 228
Seattle 227
Wilmington 222
Cambridge 183
Dong Ket 121
Beijing 117
Singapore 102
Princeton 96
Nanjing 80
Siena 74
Dearborn 51
New York 51
Helsinki 48
Shanghai 43
San Nicola la Strada 40
Boardman 39
Brussels 27
Moscow 27
San Mateo 26
Lancaster 22
Shenyang 21
Jiaxing 16
Kunming 16
Munich 16
Nanchang 16
Hebei 15
San Diego 15
Changsha 13
Los Angeles 13
Jinan 12
Phoenix 12
Tianjin 12
Düsseldorf 11
London 11
Brno 10
Florence 10
Menlo Park 10
Málaga 10
Falls Church 8
Norwalk 8
Berlin 7
Hefei 7
Izmir 7
Olomouc 7
Washington 7
Zhengzhou 7
Mestre 6
Stockholm 6
Tappahannock 6
Venezia 6
Abidjan 5
Guangzhou 5
Ningbo 5
Auburn Hills 4
Cagliari 4
Fremont 4
Fuzhou 4
Lanzhou 4
Redwood City 4
Rome 4
Toronto 4
Voghera 4
Chiswick 3
Collecorvino 3
Dallas 3
Detroit 3
Espoo 3
Frankfurt am Main 3
Gießen 3
Goiânia 3
Hangzhou 3
Lima 3
Milan 3
Naples 3
Nijkerk 3
Nuremberg 3
Pescara 3
San Francisco 3
Taizhou 3
Vientiane 3
Belo Horizonte 2
Bologna 2
Cairo 2
Chengdu 2
Cincinnati 2
Codisotto 2
Contagem 2
Copenhagen 2
Douglas 2
Falkenstein 2
Kaifeng 2
Totale 5.930
Nome #
B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function. 239
B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function 232
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 227
Anemia correction by erythropoietin reduces BNP levels, hospitalization rate, and NYHA class in patients with cardio-renal anemia syndrome. 209
Quantitative evaluation of microvessels in Behcet's disease 204
Natriuretic peptides in heart failure: where we are, where we are going. 203
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure 200
Prognostic significance of hyperuricemia in patients with acute heart failure 199
H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease 193
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 186
Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance 182
Comparison of neutrophil gelatinase-associated lipocalin versus B-type natriuretic peptide and cystatin C to predict early acute kidney injury and outcome in patients with acute heart failure 171
Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model 169
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial 166
The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions 163
Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection 162
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 161
Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure 161
Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. 159
Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application 157
null 155
Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide 154
Natriuretic peptides and NGAL in heart failure: does a link exist? 151
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study 150
Clinical impact of BNP and other emerging biomarkers in heart failure evaluation and management 147
Patients with cardiorenal syndrome revealed increased neurohormonal activity, tubular and myocardial damage compared to heart failure patients with preserved renal function 145
Diagnostic utility of contemporary echo and BNP assessment in patients with acute heart failure during early hospitalization 144
The role of natriuretic peptides for the diagnosis of left ventricular dysfunction 142
Heart failure: pathophysiology and clinical picture. 139
Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy 137
Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure 135
null 133
Left ventricular hypertrophy differences in male professional runners and in young patients suffering from mild hypertension 130
The potential role of natriuretic peptides in acute coronary syndrome stratification 125
null 122
null 120
Current therapeutic strategies in cardiorenal syndrome 119
Definizione di pattern videocapillaroscopici (VCS) di normalità nel microcircolo cutaneo. Stratificazione secondo l'età 117
null 111
Peptide natriuretico di tipo B ed ecocardiografia Doppler nella diagnosi di scompenso cardiaco: Metodiche alternative o complementari? [B-type natriuretic peptide and Doppler echocardiography in the diagnosis of heart failure: alternative or complementary tools?] 105
null 105
Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries 103
Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure 101
Dyslipidemias and fibrinolysis. 101
null 100
From gene mutations to biomechanical abnormalities and electrophysiological remodeling in hypertrophic cardiomyopathy: exploring the translational approach. 85
Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? 72
Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients 69
Clinical impact of oral antidiabetic medications in heart failure patients 68
Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction 64
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction 60
A multidisciplinary approach in neurofibromatosis 1 57
Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease: prevalence and association with exercise-induced electrocardiographic abnormalities. 56
Combined BNP and Echocardiographic assessment in interstitial lung disease for pulmonary hypertension detection 52
The prognostic combined role of B-type natriuretic peptide, blood urea nitrogen and congestion signs persistence in patients with acute heart failure 51
Arterial hypertension and atrial fibrillation: Standard and advanced echocardiography from diagnosis to prognostication 50
Effects of metolazone administration on congestion, diuretic response and renal function in patients with advanced heart failure 46
Pulmonary congestion assessment in heart failure: traditional and new tools 38
Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population (Vascular Health and Risk Management (2008) 4, 4 (877-883)) 31
Sex-related differences in chronic heart failure 30
Structural and Hemodynamic Changes of the Right Ventricle in PH-HFpEF 28
Usefulness of combined ultrasound assessment of E/e' ratio, pulmonary pressure, and cava vein status in patients with acute heart failure 21
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy 19
Right ventricular dysfunction in chronic heart failure: Clinical laboratory and echocardiographic characteristics. (the RIVED-CHF registry) 12
Totale 7.843
Categoria #
all - tutte 23.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.033 0 0 0 0 0 174 164 210 171 181 46 87
2020/20211.094 41 122 37 81 80 98 45 160 67 103 82 178
2021/2022677 36 71 32 77 63 25 29 25 39 75 67 138
2022/20231.069 64 100 143 138 118 196 24 83 88 20 35 60
2023/2024933 47 24 103 45 21 239 321 21 6 26 16 64
2024/2025741 41 74 147 111 248 120 0 0 0 0 0 0
Totale 7.843